About Pursuit vascular, inc.
Pursuit Vascular, Inc. is a medical device company that specializes in developing innovative solutions for vascular access management. The company's flagship product, the ClearGuard™ HD antimicrobial barrier cap, is a groundbreaking device that has revolutionized the way hemodialysis catheters are managed.
Hemodialysis is a life-saving treatment for patients with end-stage renal disease (ESRD). However, it comes with its own set of challenges, one of which is infection. Hemodialysis catheters are prone to bacterial colonization and biofilm formation, which can lead to serious infections such as bloodstream infections (BSIs) and sepsis.
The ClearGuard™ HD antimicrobial barrier cap addresses this problem by providing an effective barrier against infection-causing bacteria inside the catheter hub. The device uses proprietary technology to release a small amount of citrate into the lumen of the catheter hub, which prevents bacterial growth and biofilm formation.
What sets ClearGuard™ HD apart from other devices on the market is its ability to kill bacteria rather than just preventing their growth. This makes it an ideal solution for patients who are at high risk of infection or have already experienced BSIs in the past.
In addition to its efficacy in preventing infections, ClearGuard™ HD also offers several other benefits over traditional caps and connectors. It is easy to use and requires no additional training or equipment. It does not interfere with dialysis treatments or require any changes in clinical practice.
ClearGuard™ HD has been extensively tested in clinical trials and has been shown to significantly reduce rates of BSIs compared to standard care protocols. It has received FDA clearance for sale in the US and has been adopted by leading healthcare institutions across the country.
Pursuit Vascular's mission is to improve patient outcomes by providing innovative solutions that address unmet needs in vascular access management. With ClearGuard™ HD as its flagship product, Pursuit Vascular is well-positioned to make a significant impact on patient care and safety.
In conclusion, Pursuit Vascular's ClearGuard™ HD antimicrobial barrier cap represents a major breakthrough in hemodialysis catheter management. Its ability to kill infection-causing bacteria inside the catheter hub makes it an essential tool for healthcare providers who want to reduce rates of BSIs among their patients. With FDA clearance and widespread adoption across leading healthcare institutions nationwide, Pursuit Vascular is poised for continued success as a leader in vascular access management innovation.
pursuitvascular.com
